Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...

A Florida man has been arrested nearly two months after he was allegedly seen leaving the residence of a man who fell from ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun-Biotech or the Company, 6990.HK) announced that results from both ...

April 13 (Reuters) - Alamar Biosciences and Kailera Therapeutics kicked off roadshows for their U.S. initial public offerings on Monday, aiming for billion-dollar-plus valuations as biotech companies ...

Gossamer Bio is picking up the pieces after failing to bring its only late-stage drug to market. The local biotech plans to ...

Biotech held steady in early 2026 as M&A buyouts and rotation from the Magnificent Seven lifted IBB relative strength—read ...

Seaport Therapeutics has filed to go public. The buzzy Boston biotech was founded by the same team behind the local success story Karuna Therapeutics, which was bought by Bristol Myers Squibb for $14 ...

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent ...

Commit matching funds to the KC BioHub’s next federal application. Develop targeted incentives that match Missouri’s. | Opinion ...

Revolution Medicines (RVMD) is one of the best stocks on Wall Street today after breakthrough cancer pill results ...

If Biotech manages to break out to new highs at some point this year, it would clear a significant resistance hurdle and open ...